New insights into the origins of mutations in cancer
Scientists use data from human cancers and C. elegans to understand mutational causes of cancer...
List view / Grid view
Scientists use data from human cancers and C. elegans to understand mutational causes of cancer...
Scientists have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia...
Researchers have identified a protein critical for the aggressiveness of T-cell leukaemia...
Scientists have created individual cell lines in which specific blood group genes were altered to prevent the expression of blood group proteins...
Researchers have developed a new peptide format that they call double-bridged peptides...
Scientists have identified a potential therapeutic target in the devastating genetic disease Hutchinson-Gilford progeria syndrome...
A collaborative team of researchers has found that elevated levels of certain types of lipids in the brain may be an early sign of Parkinson's...
NIH-funded study closes in on personalised drug testing for neurological disorders...
A team of researchers led by the University of Missouri has employed a mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.
Obesity could enhance cancer development while aspirin might prevent it - a new insight into potential targets for cancer prevention.
Combination therapy co-targeting the mitochondria enhances the antitumour effect of telomerase inhibition in NRAS-mutant melanoma.
A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...
Researchers have shown that it is possible to identify genetic catalysts that accelerate the evolution of antibiotic resistance in bacteria...
A team of scientists have reported that tumour progression was often driven by cancer-promoting genes, known as oncogenes, on extrachromosomal pieces of DNA.
Scientists in the United States have investigated the relationship between tumour suppressor, protein kinase C zeta (PKC zeta), and metastatic colorectal cancer.